BIBLIOGRAPHY
Abdalla H., Srinivasan L., Shah S., Mayer-Barber K.D., Sher A., Sutterwala F.S., Briken V. 2012. Mycobacterium tuberculosis infection of dendritic cells leads to partially caspase-1/11- independent IL-1 and IL-18 secretion but not to pyroptosis. PLoS One. 7(7):e40722.
Abdallah A.M., Verboom T., Hannes F., Safi M., Strong M., Eisemberg D., Musters R.J., Vandenbroucke-Grauls C.M., Appelmelk B.J., Luirink J., Bitter W. 2006. A specific secretion system mediates PPE41 transport in pathogenic mycobacteria. Mol Microbiol 62:667–679.
Abdallah A.M., Gey van Pittius N.C., Champion P.A., Cox J., Luirink J., Vandenbroucke-Grauls C.M., Appelmelk B.J., Bitter W. 2007. Type VII secretion-mycobacteria show the way. Nat Rev Microbiol. 5(11):883-891.
Abdallah A.M., Savage N.D., van Zon M., Wilson L., Vandenbroucke-Grauls C.M., van der Wel N.N., Ottenhoff T.H., Bitter W. 2008. The ESX-5 secretion system of Mycobacterium marinum modulates the macrophage response. J Immunol. 181:
7166–7175.
Abdallah A.M., Verboom T., Weerdenburg E.M., Gey van Pittius N.C., Mahasha P.W., Jimenez C., Parra M., Cadieux N., Brennan M.J., Appelmelk B.J., Bitter W. 2009. PPE and PE_PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX-5. Mol Microbiol. 73:329–340.
Abdallah A.M., Bestebroer J., Savage N.D., de Punder K., van Zon M., Wilson L., Korbee C.J., van der Sar A.M., Ottenhoff T.H., van der Wel N.N., Bitter W., Peters P.J. 2011. Mycobacterial secretion systems ESX-1 and ESX-5 play distinct roles in host cell death and inflammasome activation. J Immunol. 1;187(9):4744-4753.
Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. 2007. Interleukins 1 and 6 but not transforming growth factor- beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immun. 8:942–949.
Aderem A.K., Underhill D.M. 1999. Mechanisms of phagocytosis in
macrophage. Ann Rev Immunol. 17: 593-623.
Agostini L., Martinon F., Burns K., McDermott M.F., Hawkins P.N., Tschopp J. 2004. NALP3 forms an IL-1 processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 20(3):319-325.
Akira S., Takeda K. 2004. Functions of toll-like receptors: lessons from KO mice. C R Biol. 327(6):581-589.
Akira S. 2006. TLR signaling. Curr Top Microbiol Immunol. 311:1-16.
Alderson M.R., Bement T., Day C.H., Zhu L., Molesh D., Skeiky Y.A.W. 2000. Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells. J Exp Med 191: 551–560.
Alderwick L.J., Birch H.L., Mishra A.K., Eggeling L., Besra G.S.
2007. Structure, function and biosynthesis of the Mycobacterium tuberculosis cell wall: arabinogalactan and lipoarabinomannan assembly with a view to discovering new drug targets. Biochem Soc Trans. 35:1325-1328.
Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D., Klimpel G.R., Godowski P., Zychlinsky A. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor 2. Science. 30;285(5428):736-739.
Allen I.C., Scull M.A., Moore C.B., Holl E.K., McElvania-TeKippe E., Taxman D.J., Guthrie E.H., Pickles R.J., Ting J.P. 2009. The NLRP3 inflammasome mediates in vivo innate immunity to influenza a virus through recognition of viral RNA. Immunity. 30:556–565.
Alnemri E.S., Livingston D.J., Nicholson D.W., Salvesen G., Thornberry N.A., Wong W.W., Yuan J. 1996. Human ICE/CED-3 protease nomenclature. Cell. 87:171.
Aroian R., van der Goot F.G. 2007. Pore-forming toxins and cellular non immune defenses (CNIDs). Curr Opin Microbiol. 10(1):57- 61.
Banchereau J., Steinman R.M. 1998. Dendritic cells and the
control of immunity. Nature. 19;392(6673):245-252.
Barry C.E.3rd, Boshoff H.I., Dartois V., Dick T., Ehrt S., Flynn J., Schnappinger D., Wilkinson R.J., Young D. 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. 7(12): 845-855.
Behar S.M., Divangahi M., Remold H.G. 2010. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?
Nat Rev Microbiol. 8(9):668-674.
Behar S.M., Martin C.J., Booty M.G., Nishimura T., Zhao X., Gan H.X., Divangahi M., Remold H.G. 2011. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol. 4(3):279-287.
Behr M.A., Small P.M. 1997. Molecular fingerprinting of Mycobacterium tuberculosis: how can it help the clinician? Clin Infect Dis. 25(4):806-810.
Bell D., Young J.W., Banchereau J. 1999. Dendritic cells. Adv Immunol. 72:255-324.
Beltan E., Horgen L., Rastogi N. 2000. Secretion of cytokines by human macrophages upon infection by pathogenic and non- pathogenic mycobacteria. Microb. Pathog. 28: 313–318.
Benoit M., Desnues B., Mege J.L. 2008. Macrophage polarization in bacterial infections. J Immunol. 15;181(6):3733-3739.
Besra G.S., Khoo K.H., McNeil M.R., Dell A., Morris H.R., Brennan P.J. 1995. A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy. Biochemistry. 34:4257-4266.
Bitter W., Houben E.N., Bottai D., Brodin P., Brown E.J., Cox
J.S., Derbyshire K., Fortune S.M., Gao L.Y., Liu J., Gey van
Pittius N.C., Pym A.S., Rubin E.J., Sherman D.R., Cole S.T.,
Brosch R. 2009. Systematic genetic nomenclature for type VII
secretion system. PLoS Pathog. 5(10):e1000507.
Bodnar K.A., Serbina N.V., Flynn J.L. 2001. Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect Immun. 69(2):800- 809.
Bonilla F.A, Oettgen H.C. 2010. Adaptive imunity. J Allergy Clin Immunol. 125(2 Suppl 2):S33-40.
Bottai D., Majlessi L., Simeone R., Frigui W., Laurent C., Lenormand P., Chen J., Rosenkrands I., Huerre M., Leclerc C., Cole S.T., Brosch R.2011. ESAT-6 secretion-independent impact of ESX-1 genes espF and espG1 on virulence of Mycobacterium tuberculosis. J Infect Dis. 203: 1155–1164.
Bottai D., Di Luca M., Majlessi L., Frigui W.,Simeone R., Sayes F., Bitter W., Brennan M.J., Leclerc C., Batoni G., Campa M., Brosch R., Esin S. 2012. Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. Mol Microbiol.
83(6):1195-1209.
Bowie A.G, O'Neill L.A. 2000. Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase. J Immunol. 15;165(12):7180-7188.
Boyden E.D., Dietrich W.F. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet. 38:
240–244.
Brandt L., Feino C.J., Weinreich O.A., Chilima B., Hirsch P., Appelberg R., Andersen P. 2002. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70:672-678.
Brennan P.J., Crick D.C. 2007. The cell-wall core of Mycobacterium tuberculosis in the context of drug discovery. Curr Top Med Chem.
7(5):475-488.
Brennan P.J., Nikaido H. 1995. The envelope of mycobacteria.
Annu. Rev. Biochem. 64:29-63.
Brennan P.J. 2003. Structure, function, and biogenesis of the cell
wall of Mycobacterium tuberculosis. Tuberculosis (Edinb) 83: 91–97.
Brewer T.F. 2000. Preventing tuberculosis with bacillus Calmette- Guérin vaccine: a meta-analysis of the literature. Clin Infect Dis. 31 Suppl 3:S64-67.
Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R, Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., Godowski P.J., Modlin R.L. 1999.
Host defence mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 30;285(5428):732-736.
Briken V., Porcelli S.A., Besra G.S., Kremer L. 2004.
Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 53:391-403.
Brodin P., Rosenkrands I., Andersen P., Cole S.T., Brosch R.
2004. ESAT-6 proteins: protective antigens and virulence factors?
Trends Microbiol. 12: 500–508.
Bryant C., Fitzgerald K.A. 2009. Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 19(9):455-464.
Buettner M., Meinken C., Bastian M., Bhat R., Stössel E., Faller G., Cianciolo G., Ficker J., Wagner M., Röllinghoff M., Stenger S.
2005. Inverse correlation of maturity and antibacterial activity in human dendritic cells. J Immunol. 1;174(7):4203-4209.
Bulut Y., Michelsen K.S., Hayrapetian L., Naiki Y., Spallek R., Singh M., Arditi M. 2005. Mycobaterium tuberculosis heat-shock proteins use diverse toll-like receptor pathways to activate pro- inflammatory signals. J Biol Chem. 3;280(22):20961-20967.
Burns K., Janssens S., Brissoni B., Olivos N., Beyaert R., Tschopp J. 2003. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med.
20;197(2):263-268.
Busfield S.J., Comrack C.A., Yu G., Chickering T.W., Smutko
J.S., Zhou H., Leiby K.R., Holmgren L.M., Gearing D.P., Pan Y .
2000. Identification and gene organization of three novel members of
the IL-1 family on human chromosome 2. Genomics. 66(2):213-216.
Calver A.D., Falmer A.A., Murray M., Strauss O.J., Streicher E.M., Hanekom M., Liversage T., Masibi M., van Helden P.D., Warren R.M., Victor T.C. 2010. Emergence of increased reistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerg Infect Dis. 16(2):264-271.
Camacho L.R., Constant P., Raynaud C., Laneelle M.A.,Triccas J.A., Gicquel B., Daffè M., Guilhot C. 2001. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis.
Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 276:19845-19854.
Carlsson F., Joshi S.A., Rangell L., Brown E.J. 2009. Polar localization of virulence-related ESX-1 secretion in mycobacteria.
PLoS Pathog. 5(1):e1000285.
Carlsson F., Kim J., Dumitru C., Barck K.H., Carano R.A., Sun M., Diehl L., Brown E.J. 2010. Host-detrimental role of Esx-1- mediated inflammasome activation in mycobacterial infection. PLoS Pathog. 6:e1000895.
Cassel S.L., Eisenbarth S.C., Iyer S.S., Sadler J.J., Colegio O.R., Tephly L.A., Carter A.B., Rothman P.B., Flavell R.A., Sutterwala F.S. 2008. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA.1;105(26):9035-9040.
Cerretti D.P., Kozlosky C.J., Mosley B., Nelson N., Van Ness K., Greenstreet T.A., March C.J., Kronheim S.R., Druck T., Cannizzaro L.A. 1992. Molecular cloning of the interleukin-1 beta converting enzyme. Science. 256:97–100.
Chaplin D.D. 2010. Overview of the immune response. J Allergy Clin Immunol. 125(2 Suppl 2):S3-23
Chen M., Gan H., Remold H.G. 2006. A mechanism of virulence:
virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol. 176: 3707–3716.
Choubey D., Walter S., Geng Y., Xin H. 2000. Cytoplasmatic
localization of the interferon-inducible protein that is encoded by the
AIM2 (absent in melanoma) gene from the 200 gene family. FEBS Lett. 26;474(1):38-42.
Ciaramella A., Martino A., Cicconi R., Colizzi V., Fraziano M.
2000. Mycobacterial 19-kDa lipoprotein mediates Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages at early stages of infection. Cell Death Differ. 7(12):1270-1272.
Ciaramella A., Cavone A., Santucci M.B., Amicosante M., Martino A., Auricchio G., Pucillo L.P., Colizzi V., Fraziano M.
2002. Pro-inflammatory cytokines in the course of Mycobacterium tuberculosis- induced apoptosis in monocytes/macrophages. J Infect Dis. 186(9):1277-1282.
Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry C.E. 3rd, Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krogh A., McLean J., Moule S., Murphy L., Oliver K., Osborne J., Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton J., Squares R., Squares S., Sulston J.E., Taylor K., Whitehead S., Barrell B.G.1998.
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537–544.
Cordoba-Rodriguez R., Fang H., Lankford C.S., Frucht D.M. 2004.
Anthrax lethal toxin rapidly activates caspase-1/ICE and induces extracellular release of interleukin (IL)-1beta and IL-18. J Biol Chem.
14;279(20):20563-20566.
Cook P., Tötemeyer S., Stevenson C., Fitzgerald K.A., Yamamoto M., Akira S., Maskell D.J., Bryant C.E. 2007. Salmonella-induced SipB-independent cell death requires Toll-like receptor-4 signalling via the adapter proteins Tram and Trif. Immunology. 122(2):222-229.
Cox J.S., Chen B., MacNeil M., Jacobs W.R.Jr. 1999. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature. 402: 79-83.
Craven R.R., Gao X., Allen I.C., Gris D., Bubeck Wardenburg J., McElvania-Tekippe E., Ting J.P., Duncan J.A. 2009.
Staphylococcus aureus alpha-hemolysin activates the NLRP3- inflammasome in human and mouse monocytic cells. PLoS One.
14;4(10):e7446.
Cruz C.M., Rinna A., Forman H.J., Ventura A.L., Persechini P.M., Ojcius D.M. 2007. ATP activates a reactive oxygen species- dependent oxidative stress response and secretion of pro- inflammatory cytokines in macrophages. J Biol Chem. 2;282(5):2871- 2879.
Daffè M., Brennan P.J., McNeil M. 1990. Predominant structural features of the cell wall arabinogalactan of Mycobacterium tuberculosis as revealed through characterization of oligoglycosyl alditol fragments by gas chromatography/mass spectrometry and by 1H and 13C NMR analyses. J Biol Chem. 265:6734-6743.
Daffè M, Draper P. 1998. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 39:131-203.
Daffé M. 2005. The cell envelope of corynebacteria in Corynebacterium glutamicum, p. 121-148. In L. Eggeling and M. Bott (ed.), Handbook of Corynebacterium glutamicum. CRC Press, Inc., Boca Raton, FL.
Daleke M.H., Cascioferro A., de Punder K., Ummels R., Abdallah A.M., van der Wel N.N., Peters P.J., Luirink J., Manganelli R., Bitter W. 2011. Conserved Pro-Glu (PE) and Pro-Pro-Glu (PPE) protein domains target LipY lipases of pathogenic mycobacteria to the cell surface via the ESX-5 pathway. J Biol Chem. 286: 19024–
19034.
Danilchanka O., Mailaender C., Niederweis M. 2008. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 52(7):2503-2511.
Darwin K.H., Ehrt S., Gutierrez-Ramos J.C., Weich N., Nathan C.F. 2003. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science. 12;302(5652):1963-1966.
Dick T. 2001. Dormant tubercle bacilli: he key to more effective TB chemoterapy? J Antimicrob Chemother. 47(1):117-118.
Di Luca M., Bottai D., Batoni G., Orgeur M., Aulicino A.,
Counoupas C., Campa M., Brosch R., Esin S
.2012. The ESX-5
Associated eccB-eccC Locus Is Essential for Mycobacterium
tuberculosis Viability. PLoS One. 7(12):e52059
Dinarello C.A., Cannon J.G., Mier J.W., Bernheim H.A., LoPreste G., Lynn D.L., Love R.N., Webb A.C., Auron P.E., Reuben R.C.
1986. Multiple biological activities of human recombinant interleukin 1. J Clin Invest. 77:1734–1739.
Dinarello C.A. 2004. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res. 10:201–222.
Dinarello C.A. 1996. Biologic basis for interleukin-1 in disease.
Blood. 87:2095–2147.
Dinarello C. A. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27: 519–550.
Dorhoi A., Nouailles G., Jörg S., Hagens K., Heinemann E., Pradl L., Oberbeck-Müller D., Duque-Correa M.A., Reece S.T., Ruland J., Brosch R., Tschopp J., Gross O., Kaufmann S.H. 2012.
Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis.
Eur J Immunol. 42(2):374-384.
Dostert C., Pétrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science.
2;320(5876):674-677.
Duncan J. A., Gao X., Huang M.T., O'Connor B.P., Thomas C.E., Willingham S. B., Bergstralh D.T., Jarvis G.A., Sparling P.F., Ting J.P. 2009. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol. 182:6460-6469.
Ernst J.D. 1998. Macrophage receptors for mycobacterium tuberculosis. Infect Immun. 66(4):1277-1281.
Fantuzzi G., Dinarello C.A. 1999. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J Clin Immunol.
19:1-11.
Faustin B., Lartigue L., Bruey J.M., Luciano F., Sergienko E.,
Bailly-Maitre B., Volkmann N., Hanein D., Rouiller I., Reed J.C.
2007. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell. 9;25(5):713-724.
Fernandes-Alnemri T., Yu J.W., Datta P., Wu J., Alnemri E.S.
2009. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature. 26;458(7237):509-513.
Fine P.E. 1995. Variation inprotection by BCG: implication of and for heterologous immunity. Lancet. 18;346(8986):1339-1345.
Finlay B.B., Falkow S. 1997. Common themes in microbial pathogenicity revisited. Microbiol Mol Biol. Rev. 61:136-169.
Flynn J.L., Chan J. 2001. Tuberculosis: latency and reactivation.
Infect Immun. 69(7):4195-4201.
Flynn J.L., Chan J. 2005. What's good for the host is good for the bug. Trends Microbiol. 13: 98–102.
Fortsch D., Rollinghoff M., Stenger S. 2000. IL-10 converts human dendritic cells into macrophages-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J Immunol. 15;165(2):978-987.
Fortune S.M., Solache A., Jaeger A., Hill P.J., Belisle J.T., Bloom B.R., Rubin E.J., Ernst J.D. 2004. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and –independent mechanisms. J Immunol. 15;172(10):6272-6280.
Fortune S. M., Jaeger A., Sarracino D. A., Chase M. R., Sassetti C. M., Sherman D. R., Bloom B.R., Rubin E.J. 2005. Mutually dependent secretion of proteins required for mycobacterial virulence.
Proc Natl Acad Sci USA. 102: 10676–10681.
Franchi L., Amer A., Body-Malapel M., Kanneganti T. D., Ozören N., Jagirdar R., Inohara N., Vandenabeele P., Bertin J., Coyle A., Grant E. P., Núñez G. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol. 7:576–582.
Fratti R.A., Chua J., Vergne I., Deretic V. 2003. Mycobacterium
tuberculosis glycosylated phosphatidylinositol causes phagosome
maturation arrest. Proc Natl Acad Sci USA. 29;100(9):5437-5442.
Frehel C., de Chastellier C., Offredo C., Berche P. 1991.
Intramacrophage growth of Mycobacterium avium during infection of mice. Infect Immun. 59(6):2207-2214.
Fremond C.M., Togbe D., Doz E., Rose S., Vasseur V., Maillet I., Jacobs M., Ryffel B., Quesniaux V.F. 2007. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J Immunol.
15;179(2):1178-1189.
Frigui W., Bottai D., Majlessi L., Monot M., Josselin E., Brodin P., Garnier T., Gicquel B., Martin C., Leclerc C., Cole S.T., Brosch R. 2008. Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. PloS Pathog 4: e33.
Fritz J.H., Ferrero R.L., Philpott D.J., Girardin S.E. 2006. Nod- like proteins in immunity, inflammation and disease. Nat Immunol.
7(12):1250-1257.
Garces A., Atmakuri K., Chase M.R., Woodworth J.S., Krastins B., Rothchild A. C. 2010. EspA acts as a critical mediator of ESX1- dependent virulence in Mycobacterium tuberculosis by affecting bacterial cell wall integrity. PLoS Pathog 6: e1000957.
Gao L.Y., Pak M., Kish R., Kajihara K., Brown E.J. 2006. A mycobacterial operon essential for virulence in vivo and invasion and intracellular persistence in macrophages. Infect Immun. 74(3):1757- 1767.
Gehring A.J., Dobos K.M., Belisle J.T., Harding C.V., Boom W.H.
2004. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol. 15;173(4):2660-2668.
Geijtenbeek T.B., Van Vliet S.J., Koppel E.A., Sanchez- Hernandez M., Vandenbroucke-Grauls C.M., Appelmelk B., Van Kooyk Y. 2003. Mycobacteria target DC-SIGN to suppress dendritic cells function. J Exp Med. 6;197(1):7-17.
Gerosa F., Baldani-Guerra B., Lyakh L.A., Batoni G., Esin S.,
Winkler-Pickett R.T., Consolaro M.R., De Marchi M., Giachino
D., Robbiano A., Astegiano M., Sambataro A., Kastelein R.A.,
Carra G., Trinchieri G. 2008. Differential regulation of interleukin
12 and interleukin 23 production in human dendritic cells. J Exp Med. 9;205(6):1447-1461.
Gey van Pittius N.C., Gamieldien J., Hide W., Brown G.D., Siezen R.J., Beyers A.D. 2001. The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol. 2(10): RESEARCH0044.
Giacomini E., Iona E., Ferroni L., Miettinen M., Fattorini L., Orefici G., Julkunen I., Coccia E. M. 2001. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol. 166: 7033–7041.
Goerdt S., Orfanos C.E. 1999. Other functions, other genes:
alternative activation of antigen-presenting cells. Immunity.
10(2):137-142.
Gordon S. 2003. Alternative activation of macrophages. Nat Rev Immunol. 3(1):23-35.
Gordon S.V., Bottai D., Simeone R., Stinear T.P., Brosch R. 2009.
Pathogenicity in the tubercle bacillus: molecular and evolutionary determinants. Bioessays. 31: 378–388.
Gringhuis S.I., Kaptein T.M., Wevers B.A., Theelen B., van der Vlist M., Boekhout T., Geijtenbeek T.B. 2012. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL- 1β via a noncanonical caspase-8 inflammasome. Nat Immunol.
13(3):246-254.
Gross O., Poeck H., Bscheider M., Dostert C., Hannesschlager N., Endres S., Hartmann G., Tardivel A., Schweighoffer E., Tybulewicz V., Mocsai A., Tschopp J., Ruland J. 2009. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature. 21;459(7245):433-436.
Guerardel Y., Maes E., Briken V., Chirat F., Leroy Y., Locht C.,
Strecker G., Kremer L. 2003. Lipomannan and lipoarabinomannan
from a clinical isolate of Mycobacterium kansasii: novel structural
features and apoptosis-inducing properties. J Biol Chem. 278:36637-
36651.
Guinn K.M., Hickey M.J., Mathur S.K., Zakel K.L., Grotzke J.E., Lewinsohn D.M., Smith S., Sherman D.R. 2004. Individual RD1- region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol. 51:359-370.
Janeway C.A Jr. 2001. How the immune system protects the host from infection. Microbes Infect. 3(13):1167-1171.
Janeway C.A.Jr., Medzhitov R. 2002. Innate immune recognition.
Annu Rev Immunol. 20:197-216.
Jiao X., Lo-Man R., Guermonprez P., Fiette L., Dériaud E., Burgaud S., Gicquel B., Winter N., Leclerc C. 2002. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J Immunol. 1;168(3):1294-1301.
Jin C., Flavell R.A. 2010. Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol. 30(5):628-631.
Jo E.K. 2008. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Curr Opin Infect Dis. 21:279–286.
Johnston J.B., Barret J.W., Nazarian S.H., Goodwin M., Ricciuto D., Wang G., McFadden G. 2005. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity. 23(6):587-598.
Joly S., Ma N., Sadler J.J., Soll D.R., Cassel S.L., Sutterwala F.S.
2009. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J Immunol. 183:3578–3581.
Jones G.J., Gordon S.V., Hewinson R.G., Vordermeier H.M.
2010. Screening of predicted secreted antigens from Mycobacterium bovis reveals the immunodominance of the ESAT-6 protein family.
Infect Immun. 78: 1326–1332.
Juffermans N.P., Florquin S., Camoglio L., Verbon A., Kolk A.H., Speelman P., van Deventer S.J., van Der Poll T. 2000.
Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis. 182(3):902-908.
Jung S.B., Yang C.S., Lee J.S., Shin A.R., Jung S.S., Son J.W., Harding C.V., Kim H.J., Park J.K., Paik T.H., Song C.H., Jo E.K.
2006. The mycobacterial 38-kilodalton glycoprotein antigen activates
the mitogen-activated protein kinase pathway and release of pro- inflammatory cytokines through toll-like receptors 2 and 4 in human monocytes. Infect Immun. 74(5):2686-2696.
Jungblut P. R., Schaible U. E., Mollenkopf H. J., Zimny-Arndt U., Raupach B., Mattow J., Halada P., Lamer S., Hagens K., Kaufmann S.H. 1999. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains:
towards functional genomics of microbial pathogens. Mol Microbiol.33:1103-1117.
Kahlenberg J.M., Lundberg K.C., Kertesy S.B., Qu Y., Dubyak G.R. 2005. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. J Immunol. 1;175(11):7611-7622.
Kanneganti T.D., Body-Malapel M., Amer A., Park J.H., Whitfield J., Franchi L., Taraporewala Z.F., Miller D., Patton J.T., Inohara N., Núñez G. 2006. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem. 1;281(48):36560-36568.
Kanneganti T.D., Lamkanfi M., Kim Y.G., Chen G., Park J.H., Franchi L., Vandenabeele P., Núñez G. 2007. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity.
26(4):433-443.
Karakousis P.C., Bishai W.R., Dorman S.E. 2004. Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell microbiol. 6:105-116.
Kayagaki N., Warming S., Lamkanfi M., Vande Walle L., Louie S., Dong J., Newton K., Qu Y., Liu J., Heldens S., Zhang J., Lee W.P., Roose-Girma M., Dixit V.M. 2011. Non-canonical inflammasome activation targets caspase-11. Nature. 479(7371):117- 121.
Kim K.D., Lee H.G., Kim J.K., Park S.N., Choe I.S., Choe Y.K.,
Kim S.J., Lee E., Lim J.S. 1999. Enhanced antigen-presenting
activity and tumour necrosis factor-alpha-independent activation of
dendritic cells following treatment with Mycobacterium bovis bacillus
Calmette-Guérin. Immunology. 97(4):626-633.
Kleinnijenhuis J., Joosten L.A., van de Veerdonk F.L., Savage N., van Crevel R., Kullberg B.J., van der Ven A., Ottenhoff T.H., Dinarello C.A., van der Meer J.W., Netea M.G. 2009.
Transcriptional and inflammasome-mediated pathways for the induction of IL-1beta production by Mycobacterium tuberculosis. Eur J Immunol. 39(7):1914-1922.
Kono H., Rock K.L. 2008. How dying cells alert the immune system to danger. Nat Rev Immunol. 8:279–289.
Kool M., Pétrilli V., De Smedt T., Rolaz A., Hammad H., van Nimwegen M., Bergen I.M., Castillo R., Lambrecht B.N., Tschopp J. 2008. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol. 181:3755–3759.
Koo I. C., Wang C., Raghavan S., Morisaki J.H., Cox J.S., Brown E.J
.2008. ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection. Cell Microbiol.10:1866-1878.
Kostura M.J., Tocci M.J., Limjuco G., Chin J., Cameron P., Hillman A.G., Chartrain N.A., Schmidt J.A. 1989. Identification of a monocyte specific pre-interleukin 1 convertase activity. Proc Natl Acad Sci USA. 86:5227–5231.
Kumar S., McDonnell P.C., Lehr R., Tierney L., Tzimas M.N., Griswold D.E., Capper E.A., Tal-Singer R., Wells G.I., Doyle M.L., Young P.R. 2000. Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem.
275(14):10308-10314.
Kurenuma T., Kawamura I., Hara H., Uchiyama R., Daim S., Dewamitta S.R., Sakai S., Tsuchiya K., Nomura T., Mitsuyama M. 2009. The RD1 locus in the Mycobacterium tuberculosis genome contributes to activation of caspase-1 via induction of potassium ion efflux in infected macrophages. Infect Immun. 77(9):3992-4001.
Halle A., Hornung V., Petzold G.C., Stewart C.R., Monks B.G.,
Reinheckel T., Fitzgerald K.A., Latz E., Moore K.J., Golenbock
D.T. 2008. The NALP3 inflammasome is involved in the innate
immune response to amyloid-beta. Nat Immunol. 9(8):857-865.
Haraldsen G., Balogh J., Pollheimer J., Sponheim J., Kuchler A.M. 2009. Interleukin-33 - cytokine of dual function or novel alarmin? Trends Immunol. 30: 227-233.
Henderson R.A., Watkins S.C., Flynn J.L. 1997. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol. 15;159(2):635-643.
Hestvik A.L., Hmama Z., Av-Gay Y. 2005. Mycobacterial manipulation of the host cell. FEMS Microbiol. Rev. 29:1041–1050.
Hickman S.P., Chan J., Salgame P. 2002. Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. J Immunol. 1;168(9):4636-4642.
Hirsch C.S., Ellner J.J, Russell D.G., Rich E.A. 1994. Complement receptor-mediate uptake and tumor necrosis factor-alpha-mediated growth inibition of Mycobacterium tuberculosis by human alveolar macrophage. J immunol. 152:743-753.
Hise A.G., Tomalka J., Ganesan S., Patel K., Hall B.A., Brown G.D., Fitzgerald K.A. 2009. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe. 5:487–497.
Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K. L., Fitzgerald K. A., Latz E. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 9:847-856.
Horsburgh C.R.Jr. 1991. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 324(19):
1332-1338.
Horwood N.J., Udagawa N., Elliott J., Grail D., Okamura H., Kurimoto M., Dunn A.R., Martin T., Gillespie M.T. 1998.
Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest.
101: 595–603.
Hsu T., Hingley-Wilson S.M., Chen B., Chen M., Dai A.Z., Morin
P.M., Marks C.B., Padiyar J., Goulding C., Gingery M., Eisenberg
D.,Russell R.G., Derrick S.C., Collins F.M., Morris S.L., King C.H.
and Jacobs W.R. Jr. 2003. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci USA.100:12420-12425.
Ichinohe T., Lee H.K., Ogura Y., Flavell R., Iwasaki A. 2009.
Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med. 206:79–87.
Inohara H., Chamaillard M., McDonald C., Nuñez G. 2005. NOD- LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem. 74:355-383.
Lamkanfi M. and Dixit V.M. 2009. Inflammasomes: guardians of cytosolic. Immunological Reviews. 227: 95–105.
Laochumroonvorapong P., Paul S., Manca C., Freedman V.H., Kaplan G. 1997. Mycobacterial growth and sensitivity to H2O2 killing in human monocyte in vitro. Infect Immun. 65(11):4850-4857.
Lavollay M., Arthur M., Fourgeaud M., Dubost L., Arul M., Veziris N., Blanot D., Gutmann L., Mainardi J. 2008. The Peptidoglycan of Stationary-Phase Mycobacterium tuberculosis Predominantly Contains Cross-Links Generated by l,d-Transpeptidation. J Bacteriol.
190(12):4360-4366.
Lee J., Hartman M., Kornfeld H. 2009. Macrophage apoptosis in tuberculosis. Yonsei Med J. 50:1–11.
Lee J., Repasy T., Papavinasasundaram K., Sassetti C., Kornfeld H. 2011. Mycobacterium tuberculosis induces an atypical cell death mode to escape from infected macrophages. PLoS One. 6:e18367.
Lewis K.N., Liao R., Guinn K.M., Hickey M.J., Smith S., Behr M.A., Sherman D.R. 2003. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J Infect Dis. 187:117-123.
Liu J., Rosenberg E.Y., and Nikaido H. 1995. Fluidity of the lipid domain of cell wall from Mycobacterium chelonae. Proc Natl Acad Sci USA. 92:11254-11258.
Lipscomb M.F., Masten B.J. 2002. Dendritic cells: immune
regulators in health and desease. Physiol Rev. 82(1):97-130.
Littmann M., Albiger B., Frentzen A., Normark S., Henriques- Normark B., Plant L. 2009. Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression. EMBO Mol Med. 1(4):211-222.
Lopez M., Sly L. M., Luu Y., Young D., Cooper H., Reiner N.E.
2003. The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J Immunol. 170:
2409–2416.
MacGurn J.A., Raghavan S., Stanley S.A., Cox, J.S. 2005. A non- RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis. Mol Microbiol. 57:1653–1663.
MacMicking J.D., North R.J., LaCourse R., Mudgett J.S., Shah S.K., Nathan C.F. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA.
13;94(10):5243-5248.
Madigan M., Martinko J. 2005. Brock Biology of Microorganisms.
11th Edn., Prentice Hall, New Jersey, USA.
Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25(12):677-686.
Mantovani A., Sica A., Locati M. 2005. Macrophage polarization comes of age. Immunity. 23(4):344-346.
Mariathasan S., Newton K., Monack D.M., Vucic D., French D.M., Lee W.P., Roose-Girma M., Erickson S., Dixit V.M. 2004.
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature. 8;430(6996):213-218.
Mariathasan S., Weiss D.S., Newton K., McBride J., O’Rourke K., Roose- Girma M., Lee W.P., Weinrauch Y., Monack D.M., Dixit V.M. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 440:228–232.
Mariathasan S., Monack D.M. 2007. Inflammasome adaptors and
sensors: intracellular regulators of infection and inflammation. Nat
Rev Immunol. 7(1):31-40.
Marina-García N., Franchi L., Kim Y.G., Miller D., McDonald C., Boons G.J., Núñez G. 2008. Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2. J Immunol.
15;180(6):4050-4057.
Marmiesse M., Brodin P., Buchrrieser C., Gutierrez C., Simoes N., Vincent V., Glaser P., Cole S.. Brosch R. 2004. Macro-array and Bionformatic analyses reveal mycobacterial core genes variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex. Microbiology. 150: 483-496.
Martinon F., Burns K., Tschopp J. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 10(2):417-426.
Martinon F., Tschopp J. 2004. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases.
Cell. 28;117(5):561-574.
Martinon F., Agostini L., Meylan E., Tschopp J. 2004.
Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol. 9;14(21):1929-1934.
Martinon F., Mayor A., Tschopp J. 2009. The inflammasomes:
guardians of the body. Annu Rev Immunol. 27:229–265.
Master S.S., Rampini S.K., Davis A.S., Keller C., Ehlers S., Springer B., Timmins G.S., Sander P., Deretic V. 2008.
Mycobacterium tuberculosis presents inflammasome activation. Cell Host Microbe. 17;3(4):224-232.
Mayer-Barber K.D., Barber D., Shenderov K., White S.D., Wilson M.S., Cheever A., Kugler D. Hieny S., Caspar P., Núñez G., Schlueter D., Flavell R.A., Sutterwala F.S., Sher A. 2010.
Caspase-1 independent IL-1beta production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol. 184: 3326–3330.
Maxwell J.R., Yadav R., Rossi R.J., Ruby C.E., Weinberg A.D., Aguila H.L., Vella A.T. 2006. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J Immunol.
177:234–245.
McKean D.J., Nilson A., Beck B.N., Giri J., Mizel S.B., Handwerger B.S. 1985. The role of IL 1 in the antigen-specific activation of murine class II-restricted T lymphocyte clones. J Immunol. 135:3205–3216.
McLaughlin B., Chon J.S., MacGurn J.A., Carlsson F., Cheng T.L., Cox J.S., Brown E.J. 2007. A mycobacterium ESX-1-secreted virulence factor with unique requirements for export. PLoS Pathog 3:
e105.
McNeil M., Daffe M., Brennan P.J. 1990. Evidence for the nature of the link between the arabinogalactan and peptidoglycan of mycobacterial cell walls. J Biol Chem. 265:18200-18206.
McNeil M.R. and Brennan P.J. 1991. Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information. Res Microbiol. 142:451-463.
Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature. 18;449(7164):819-826.
Meixenberger K., Pache F., Eitel J., Schmeck B., Hippenstiel S., Slevogt H., N'Guessan P., Witzenrath M., Netea M.G., Chakraborty T., Suttorp N., Opitz B. 2010. Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3. J Immunol. 15;184(2):922-930.
Mellman I., Steinman R.M. 2001. BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Rev Vaccines. 9(2):209-222.
Merle C.S., Cuhna S.S., Rodrigues L.C. 2010. Dendritic cells:
specialized and regulated antigen processing machines. Cell.
106(3):255-258.
Meylan E., Tschopp J., Karin M. 2006. Intracellular pattern recognition receptors in the host response. Nature. 6;442(7098):39- 44.
Miao E.A., Alpuche-Aranda C.M., Dors M., Clark A.E., Bader
M.W., Miller S.I., Aderem A. 2006. Cytoplasmic flagellin activates
caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7:569–575.
Miller D.K., Ayala J.M., Egger L.A., Raju S.M., Yamin T.T., Ding G.J., Gaffney E. P., Howard A.D., Palyha O.C., Rolando A.M.
1993. Purification and characterization of active human interleukin- 1 beta-converting enzyme from THP.1 monocytic cells. J Biol Chem.
268:18062–18069.
Miller B.H., Fratti R.A., Poschet J.F., Timmins G.S., Master S.S., Burgos M., Marletta M.A., Deretic V. 2004. Mycobacteria inhibits nitric oxide synthase recruitment to phagosomes during macrophage infection. Infect Immun. 72(5):2872-2878.
Minnikin D.E. 1991 Chemical principles in the organization of lipid components in the mycobacterial cell envelope. Res Microbiol.
142:423-427.
Minnikin D.E., Kremer L., Dover L.G., and Besra G. S. 2002. The methyl-branched fortifications of Mycobacterium tuberculosis. Chem.
Biol. 9:545-553.
Mishra B. B., Moura-Alves P., Sonawane A., Hacohen N., Griffiths G., Moita L. F., Anes E. 2010. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol. 12:1046-1063.
Molofsky A.B., Byrne B.G., Whitfield N.N., Madigan C.A., Fuse E.T., Tateda K., Swanson M.S. 2006. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J Exp Med. 17;203(4):1093-1104.
Montero M.T., Matilla J., Gómez-Mampaso E., Lasunción M.A.
2004. Geranylgeraniol regulates negatively caspase-1 autoprocessing: implication in the Th1 response against Mycobacterium tuberculosis. J Immunol. 15;173(8):4936-4944.
Naik S.H. 2008. Demystifying the development of dendritic cell subtypes, a little. Immunol cell biol. 86(5):439-452.
Nau G.J., Richmond J.F.L., Schlesinger A., Jennings E.G., Lander E.S., Young. R.A. 2002. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA.
99:1503–1508.
Netea M.G., Azam T., Lewis E.C., Joosten L.A., Wang M., Langenberg D., Meng X., Chan E.D., Yoon D.Y., Ottenhoff T., Kim S.H., Dinarello C.A. 2006. Mycobacterium Tuberculosis Induces Interleukin-32 Production Through A Caspase- 1/IL-18/Interferon- Gamma-Dependent Mechanism. Plos Med. 3(8):e277.
Netea M.G., Nold-Petry C.A., Nold M.F., Joosten L.A., Opitz B., van der Meer J.H., van de Veerdonk F.L., Ferwerda G., Heinhuis B., Devesa I., Funk C.J., Mason R.J., Kullberg B.J., Rubartelli A., van der Meer J.W., Dinarello C.A. 2009. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood. 5;113(10):2324- 2335.
Netea M.G., Simon A., van de Veerdonk F., Kullberg B.J., Van der Meer J.W., Joosten L.A. 2010. IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog.
26;6(2):e1000661.
Nightingale S.D., Byrd L.T., Southern P.M., Jockusch J.D., Cal S.X., Wynne B.A. 1992. Incidence of Mycobacterium avium- intracellular complex bacteremia in human immunodeficiency virus- positive patients. J Infect Dis. 1992. 165(6):1082-1085.
Nigou J., Zelle-Rieser C., Gilleron M., Thurnher M., Puzo G.
2001. Mannosylated lipoarabinomannans inhibits IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J Immunol. 15;166(12):7477-7485.
Noss E.H., Pai R.K., Sellati T.J., Radolf J.D., Belisle J., Golenbock D.T., Boom W.H., Harding C.V. 2001. Toll like receptor 2 dependent ihnibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol. 15;167(2):910-918.
Novikov A., Cardone M., Thompson R., Shenderov K., Kirschman K.D., Mayer-Barber K.D., Myers T.G., Rabin R.L., Trinchieri G., Sher A., Feng C.G. 2011. Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1 production in human macrophages. J Immunol.1;187(5):2540-2547.
Oddo M., Renno T., Attinger A., Bakker T., MacDonald H. R.,
Meylan P.R. 1998. Fas ligand-induced apoptosis of infected human
macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol. 160:5448–5454.
Orme I.M, Cooper A.M. 1999. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today. 1;20(7):307-312.
Ottenhoff T.H., Verreck F.A., Lichtenauer-Kaligis E.G., Hoeve M.A., Sanal O., van Dissel J.T. 2002. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet. 32(1):97-105.
Pallen M.J. 2002. The ESAT-6/WXG100 superfamily -- and a new Gram-positive secretion system? Trends Microbiol. 10:209-212.
Park J.S., Tamayo M.H., Gonzalez-Juarrero M., Orme I.M., Ordway D.J. 2006. Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages. J Leukoc Biol. 79:80–86.
Parrish N.M., Dick J.D., Bishai W. R.1998. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 6(3):107-112.
Pechkvosky D.V., Goldmann T., Vollmer E., Muller-Quemheim J., Zissel G. 2006. Interleukin-18 expression by alveolar epithelial cells type II in tuberculosis and sarcoidosis. FEMS immunol Med Microbiol. 46(1):30-38.
Pecora N.D., Gehring A.J., Canaday D.H., Boom W.H., Harding C.V. 2006. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J Immunol. 1;177(1):422-429.
Pedra J.H., Cassel S.L., Sutterwala F.S. 2009. Sensing Pathogens and Danger Signals by the Inflammasome. Curr Opin Immunol.
21(1):10-16.
Pétrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ.14(9):1583- 1589.
Piccini A., Carta S., Tassi S., Lasiglié D., Fossati G., Rubartelli A.
2008. ATP is released by monocytes stimulated with pathogen-
sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA. 10;105(23):8067-8072.
Pieters J., Ploegh H. 2003. Microbiology. Chemical warfare and mycobacterial defence. Science. 12;302(5652):1900-1902.
Proell M., Riedl S.J., Fritz J.H., Rojas A.M., Schwarzenbacher R.
2008. The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS One. 3:e2119.
Puech V., Chami M., Lemassu A., Laneelle M.A., Schiffler B., Gounon P., Bayan N., Benz R., and Daffé M. 2001. Structure of the cell envelope of corynebacteria: importance of the non-covalently bound lipids in the formation of the cell wall permeability barrier and fracture plane. Microbiology. 147:1365-1382.
Pym A.S., Brodin P., Brosch R., Huerre M., Cole S.T. 2002.Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol.
46:709-717.
Pym A.S., Brodin P., Majlessi L., Brosch R., Demangel C., Williams A., Griffiths K.E., Marchal G., Leclerc C., Cole S.T.
2003. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med. 9:533-539.
Raghavan S., Manzanillo P., Chan K., Dovey C., Cox J.S. 2008.
Secrete transcription factor control Mycobacterium tuberculosis virulence. Nature. 454(7205):717-721.
Raja A. 2004. Immunology of tuberculosis. Indian J Med Res.
120(4):213-232.
Rasmussen S.B, Reinert L.S, Paludan S.R. 2009. Innate recognition of intracellular pathogens: detection and activation of the first line of defence. APMIS. 117(5-6):323-337.
Rastogi N. 1991. Recent observations concerning structure and function relationships in the mycobacterial cell envelope: elaboration of a model in terms of mycobacterial pathogenicity, virulence and drug-resistance. Res Microbiol. 142:464-476.
Reig N., Jiang A., Couture R., Sutterwala F.S., Ogura Y., Flavell
R.A., Mellman I., van der Goot F.G. 2008. Maturation modulates
caspase-1 independent response of dendritic cells to anthrax lethal toxin. Cell Microbiol. 10(5):1190-1207.
Ren T., Zamboni D.S., Roy C.R., Dietrich W.F., Vance R.E. 2006.
Flagellin-deficient Legionella mutants evade caspase-1- and Naip5- mediated macrophage immunity. Plos Pathog. 2(3):e18.
Riley R.L., Mills C.C., Nyka W., Weinstock N., Storey P.B., Sultan L.U., Riley M. C., Wells W.F. 1995. Aerial dissemination of pulmonary tuberculosis: a two-year study of contagion in a tuberculosis ward. Am J Epidemiol. 142:3–14.
Riteau N., Baron L., Villeret B., Guillou N., Savigny F., Ryffel B., Rassendren F., Le Bert M., Gombault A., Couillin I. 2012. ATP release and purinergic signaling: a common pathway for particle- mediated inflammasome activation. Cell Death Dis. 11;3:e403.
Roberts T.L., Idris A., Dunn J.A., Kelly G.M., Burnton C.M., Hodgson S., Hardy L.L., Garceau V., Sweet M.J., Ross I.L., Hume D.A., Stacey K.J. 2009. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science.
20;323(5917):1057-1060.
Rock K.L., Latz E., Ontiveros F., Kono H. 2010. The sterile inflammatory response. Annu Rev Immunol. 28:321-342.
Rodrigues L.C., Diwan V.K., Wheeler J.G. 1993. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 22(6):1154-1158.
Rohde K.H., Abramovitch R.B., Russell D.G. 2007. Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host Microbe. 15;2(5):352- 364.
Rosenkrands I., Weldingh K., Jacobsen S., Hansen C.V., Florio W., Gianetri I., Andersen P. 2000. Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional del electrophoresis, microsequencing and immunodetection.
Electrophoresis. 21:935-948.
Russel D. G. 2007. Who puts the tubercle in tuberculosis? Nat Rev
Microbiol. 5(1):39-47.
Russell D.G., Cardona P.J., Kim M.J., Allain S., Altare F. 2009.
Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol. 10(9):943-948.
Sallusto F, Lanzavecchia A. 1999. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med.
15;189(4):611-614.
Salvesen G.S., Abrams J.M. 2004. Caspase activation: stepping on the gas or releasing the breaks? Lessons from human and flies.
Oncogene. 12;23(16):2774-2784.
Sani M., Houben E.N., Geurtsen J., Pierson J., de Punder K., van Zon M., Wever B., Piersma S.R., Jiménez C.R., Daffé M., Appelmelk B.J., Bitter W., van der Wel N., Peters P.J. 2010.
Direct visualization by cryo-EM of the mycobacterial capsular layer:
a labile structure containing ESX-1-secreted proteins. PLoS Pathog 6: e1000794.
Sayes F., Sun L., Di Luca M., Simeone R., Degaiffier N., Fiette L., Esin S., Brosch R., Bottai D., Leclerc C., Majlessi L. 2012. Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential. Cell Host Microbe. 11(4):352-363.
Schäfer G., Guler R., Murray G., Brombacher F., Brown G.D.
2009. The role of scavanger receptor B1 in infection with Mycobacterium tuberculosis in a murine model. PLoS One.
24;4(12):e8448.
Schlesinger L.S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J immunol.
150: 2920-2930.
Schlesinger L.S., Kaufmann T.M., Iyer S., Hull S.R., Marchiando L.K. 1996. Difference in mannose receptor-mediate uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophage. J Immunol. 157:
4568-4575.
Serafini A., Boldrin F., Palù G., Manganelli R. 2009.
Characterization of a Mycobacterium tuberculosis ESX-3 conditional
mutant: essentiality and rescue by iron and zinc. J Bacteriol.
191(20):6340-6344.
Serbina N.V., Lazarevic V., Flynn J.L. 2001. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. J Immunol. 15;167(12):6991- 7000.
Sica A., Schioppa T., Mantovani A., Allavena P. 2005. Tumour- associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 42(6):717-727.
Siegrist M.S., Unnikrishnan M., McConnell M.J., Borowsky M., Cheng T.Y., Siddiqi N., Fortune S.M., Moody D.B., Rubin E.J.
2009. Mycobacterial ESX-3 is required for mycobactin mediated iron acquisition. Proc Natl Acad Sci USA. 3;106(44):18792-18797.
Silverman W.R., de Rivero Vaccari J.P., Locovei S., Qiu F., Carlsson S.K., Scemes E., Keane R.W., Dahl G. 2009. The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem. 3;284(27):18143-18151.
Simeone R., Bottai D., Brosch R. 2009. ESX/type VII secretion systems and their role in host-pathogen interaction. Curr Opin Microbiol 12: 4–10.
